Wen Lin

Also affiliated with Chinese Academy of Medical Sciences & Peking Union Medical College, TEDA International Cardiovascular Hospital, Shantou University, Cancer Hospital of Shantou University Medical College, Luoyang Central Hospital Affiliated to Zhengzhou University, Guangdong Academy of Medical Sciences, Southern Medical University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials”.

Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004273

N/A

0.753DataRank · unranked

21 citations

Martin Reck, Paul Nghiem, Feng Yan, Gregory E. Plautz, Hye Ryun Kim +10 more

Regulation of Nrf2 Transactivation Domain Activity by p160 RAC3/SRC3 and Other Nuclear Co-Regulators

BMB Reports(2006)10.5483/bmbrep.2006.39.3.304

N/A

0.561DataRank · unranked

41 citations

Guoxiang Shen, Xiaoling Yuan, Mohit R. Jain, Siwang Yu, Aihua Zhang +3 more